Steele, V. E., Wargovich, M. J., McKee, K., Sharma, S., Wilkinson, B. P., Wyatt, G. P., . . . Kelloff, G. J. (1998). Cancer Chemoprevention Drug Development Strategies for Resveratrol. Pharmaceutical Biology, 36, 62. https://doi.org/10.1076/phbi.36.6.62.4552
Chicago Style (17th ed.) CitationSteele, Vernon E., Michael J. Wargovich, Kathy McKee, Sheela Sharma, Betty P. Wilkinson, Gail P. Wyatt, Pu Gao, and Gary J. Kelloff. "Cancer Chemoprevention Drug Development Strategies for Resveratrol." Pharmaceutical Biology 36 (1998): 62. https://doi.org/10.1076/phbi.36.6.62.4552.
MLA (9th ed.) CitationSteele, Vernon E., et al. "Cancer Chemoprevention Drug Development Strategies for Resveratrol." Pharmaceutical Biology, vol. 36, 1998, p. 62, https://doi.org/10.1076/phbi.36.6.62.4552.